V. J. Haupt

发表

Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network.

M. Schroeder, Simone Daminelli, V. J. Haupt, 2012, Integrative biology : quantitative biosciences from nano to macro.

The structural basis of the genetic code: amino acid recognition by aminoacyl-tRNA synthetases

M. Schroeder, V. J. Haupt, D. Labudde, 2020, Scientific Reports.

The structural basis of the genetic code: amino acid recognition by aminoacyl-tRNA synthetases

M. Schroeder, V. J. Haupt, D. Labudde, 2019, Scientific Reports.

Characterization of Amino Acid Recognition in Aminoacyl-tRNA Synthetases

M. Schroeder, V. J. Haupt, D. Labudde, 2019 .

Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.

M. Schroeder, Simone Daminelli, V. J. Haupt, 2014, Progress in biophysics and molecular biology.

From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns

Melissa F. Adasme, M. Schroeder, Simone Daminelli, 2017, Scientific Reports.

Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key

Michael Schroeder, Simone Daminelli, V. Joachim Haupt, 2013, PloS one.

Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling

M. Schroeder, V. J. Haupt, E. Saavedra, 2020, International journal of molecular sciences.

Computational Drug Repositioning by Target Hopping: A Use Case in Chagas Disease.

Janez Konc, M. Schroeder, Simone Daminelli, 2016, Current pharmaceutical design.

Focus Your Screening Library: Rapid Identification of Novel PDE2 Inhibitors with in silico Driven Library Prioritization and MicroScale Thermophoresis

Maximilian G. Plach, V. J. Haupt, T. Schubert, 2020, bioRxiv.

Backbone Brackets and Arginine Tweezers delineate Class I and Class II aminoacyl tRNA synthetases

M. Schroeder, V. J. Haupt, D. Labudde, 2018, bioRxiv.

New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells

M. Schroeder, V. J. Haupt, Yixin Zhang, 2016, Oncotarget.

Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor

Melissa F. Adasme, Y. Moreau, M. Schroeder, 2019, bioRxiv.

Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor

Melissa F. Adasme, Y. Moreau, M. Schroeder, 2019, bioRxiv.

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning

Melissa F. Adasme, Sarah Naomi Bolz, M. Schroeder, 2020, International journal of molecular sciences.

Pioneering topological methods for network-based drug–target prediction by exploiting a brain-network self-organization theory

Michael Schroeder, Simone Daminelli, V. Joachim Haupt, 2017, Briefings Bioinform..

Backbone Brackets and Arginine Tweezers delineate Class I and Class II aminoacyl tRNA synthetases

Michael Schroeder, V. Joachim Haupt, Sebastian Bittrich, 2018, bioRxiv.

The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitors.

V. J. Haupt, S. Chou, H. Sticht, 2016, Antiviral research.

In Silico Driven Prediction of MAPK14 Off-Targets Reveals Unrelated Proteins with High Accuracy

Maximilian G. Plach, V. J. Haupt, Florian Kaiser, 2020, bioRxiv.

Discovery of Mycobacterium tuberculosis InhA Inhibitors by Binding Sites Comparison and Ligands Prediction.

Michael Schroeder, Feng Liu, Thierry Langer, 2016, Journal of medicinal chemistry.

PLIP: fully automated protein–ligand interaction profiler

Michael Schroeder, V. Joachim Haupt, Sven Schreiber, 2015, Nucleic Acids Res..

PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA

Melissa F. Adasme, Sarah Naomi Bolz, M. Schroeder, 2021, Nucleic Acids Res..

Old friends in new guise: repositioning of known drugs with structural bioinformatics

Michael Schroeder, V. Joachim Haupt, M. Schroeder, 2011, Briefings Bioinform..

From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns

Melissa F. Adasme, M. Schroeder, Simone Daminelli, 2017, Scientific Reports.

Correction: Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key

Michael Schroeder, Simone Daminelli, V. Joachim Haupt, 2013, PLoS ONE.

An interaction-based drug discovery screen explains known SARS-CoV-2 inhibitors and predicts new compound scaffolds

V. J. Haupt, Klevia Dishnica, Florian Kaiser, 2023, Scientific reports.

Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor

Sarah Naomi Bolz, V. J. Haupt, Sebastian Salentin, 2021, Computational and structural biotechnology journal.

Privacy-Preserving Cloud Computing for Biomedical Research

Michael Schroeder, Martin Beck, V. Joachim Haupt, 2014, Trusted Cloud Computing.